Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PVS1PP5_Moderate
The NM_015215.4(CAMTA1):c.116-17_117delTGTTTTCTTCTTTGTAGAT(p.Asp39fs) variant causes a frameshift, splice acceptor, splice region, intron change. The variant was absent in control chromosomes in GnomAD project. It is difficult to determine the true allele frequency of this variant because it is of type DEL_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Likely pathogenic (★). Variant results in nonsense mediated mRNA decay.
CAMTA1 (HGNC:18806): (calmodulin binding transcription activator 1) The protein encoded by this gene contains a CG1 DNA-binding domain, a transcription factor immunoglobulin domain, ankyrin repeats, and calmodulin-binding IQ motifs. The encoded protein is thought to be a transcription factor and may be a tumor suppressor. However, a translocation event is sometimes observed between this gene and the WWTR1 gene, with the resulting WWTR1-CAMTA1 oncoprotein leading to epithelioid hemangioendothelioma, a malignant vascular cancer. [provided by RefSeq, Mar 2017]
CAMTA1 Gene-Disease associations (from GenCC):
cerebellar dysfunction with variable cognitive and behavioral abnormalities
Our verdict: Pathogenic. The variant received 10 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PP5
Variant 1-6825072-TATTGTTTTCTTCTTTGTAG-T is Pathogenic according to our data. Variant chr1-6825072-TATTGTTTTCTTCTTTGTAG-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 3893251.Status of the report is criteria_provided_single_submitter, 1 stars.
Cerebellar dysfunction with variable cognitive and behavioral abnormalitiesPathogenic:1
Oct 24, 2023
Illumina Laboratory Services, Illumina
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing
The CAMTA1 c.116-17_117del variant results in the deletion of 19 nucleotides in the splice region of intron 2, including the consensus splice acceptor site, which may result in splicing defects. To our knowledge, this variant has not been reported in the peer-reviewed literature. The c.116-17_117del variant is not observed in version 2.1.1 or version 3.1.2 of the Genome Aggregation Database. Based on the available evidence, the c.116-17_117del variant is classified as likely pathogenic for cerebellar dysfunction with variable cognitive and behavioral abnormalities. -